Dr. Solomon Carter Fuller was the first Black psychiatrist and neurologist in the United States but has long been overlooked.
A new study has shown that two drugs - lecanemab and donanemab - could help patients stay independent by approximately 10–13 ...
2d
Medpage Today on MSNFor Your Patients: Navigating Treatment Options in Early Stage Alzheimer’s DiseaseWith early diagnosis of Alzheimer's disease comes the possibility of treatment to not only help manage symptoms but also slow ...
Myra Solano Garcia, who has Alzheimer's, says the drug Kisunla may be one reason she can still drive, cook, and sing.
5h
News Medical on MSNStudy reveals how air pollution contributes to Alzheimer's diseaseAir pollution contributes to nearly 7 million premature deaths each year, and its effects go far beyond the lungs.
A 75-year-old man with a genetic predisposition for Alzheimer’s has yet to show signs of the disease. Could this offer ...
A fascinating collaborative study in 2022, between researchers at the University of Oxford and Tufts University, suggested ...
Scientists think they've found a link between Alzheimer's disease and a subtle change to a person's breathing habit.
Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband ...
A team of scientists at the Indiana University School of Medicine has identified that an eye condition affecting the retina, ...
3d
News Medical on MSNHerpesviruses may contribute to Alzheimer's disease via transposable elementsResearchers from Cleveland Clinic's Genome Center have outlined the pathway human herpes simplex virus-1 (HSV1) can use to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results